Latest Intelligence on General Business in Brazil

Published within

« | 1 | 2 | » »|

Type Product title / description Pub Price
CommentWire
CommentWire

Bimbo: time to decide between North and South

Published By Datamonitor
20 Mar 2001
CommentWire
CommentWire

Bayer: choosing Dendrite for salesforce support

Published By Datamonitor
13 Jun 2001
CommentWire
CommentWire

Brazilian autos: positioning the key to survival

Published By Datamonitor
05 Oct 2001
ResearchWire
ResearchWire

Brazilian drinks: AmBev bubbling up with the beer

Published By Datamonitor
13 Nov 2001
CommentWire
CommentWire

Kuehne & Nagel: taking over the world, with minimal risk

K&N can now fully integrate the unit's activities into its network, controlling the subsidiary's operations for the benefit of its global network. Setting up joint ventures and turning the successful ones into wholly owned subsidiaries is a wise strategy for K&N. It can test the waters in each market before putting forward full capital and resource commitment.

Published By Datamonitor
20 Feb 2002
ResearchWire
ResearchWire

Trauma devices: Chinese market to grow 168%

Published By Datamonitor
12 Mar 2002
ResearchWire
ResearchWire

Trauma devices: IM nailing set for take-off in Brazil

Published By Datamonitor
12 Apr 2002
CommentWire
CommentWire

Emerging markets: Wall Street backs the samba boys

Wall Street fears that a Brazil defeat in tomorrow's England soccer match could destabilize the country's volatile stock markets and weaken the right wing government's electoral chances. The US is largely unmoved by soccer - but if Brazil were to follow Argentina into meltdown, this would seriously affect American financial interests.

Published By Datamonitor
20 Jun 2002
CommentWire
CommentWire

Corus: muddled thinking

When Corus was formed in 1999, it hoped to grow by diversifying from steel - but a corporate rethink has overturned these plans. Not only is the firm now spinning off its non-steel businesses, it's merging with Brazil's CSN, thereby guaranteeing ore supplies. It's not clear that heavy exposure to a rickety economy is the best way of hedging commodity price risk, however.

Published By Datamonitor
21 Aug 2002
CommentWire
CommentWire

HIV patents: no solution - yet

While the WTO has not yet made a breakthrough on the issue of patent-free HIV drugs for developing economies, something must be done to alleviate the human and economic cost of the HIV epidemic. Western pharma companies will inevitably lose out - the only question is how well their profit maintenance strategies can cushion the blow.

Published By Datamonitor
22 Oct 2002

« | 1 | 2 | » »|

No help is available.